A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients.
Lu JH, Zuo ZX, Wang W, Zhao Q, Qiu MZ, Luo HY, Chen ZH, Mo HY, Wang F, Yang DD, Wang Y, Wei XL, Wu QN, Ju HQ, Xu RH, Zeng ZL.
Lu JH, et al. Among authors: zeng zl.
Cell Death Discov. 2018 Dec 18;4:116. doi: 10.1038/s41420-018-0133-7. eCollection 2018.
Cell Death Discov. 2018.
PMID: 30588338
Free PMC article.